420 related articles for article (PubMed ID: 16255847)
1. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy].
Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847
[TBL] [Abstract][Full Text] [Related]
2. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
Guo CY; Ronen GM; Atkinson SA
Epilepsia; 2001 Sep; 42(9):1141-7. PubMed ID: 11580761
[TBL] [Abstract][Full Text] [Related]
3. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.
Heo K; Rhee Y; Lee HW; Lee SA; Shin DJ; Kim WJ; Song HK; Song K; Lee BI
Epilepsia; 2011 Oct; 52(10):1884-9. PubMed ID: 21692779
[TBL] [Abstract][Full Text] [Related]
4. Vascular function and risk factors in children with epilepsy: associations with sodium valproate and carbamazepine.
Keenan N; Sadlier LG; Wiltshire E
Epilepsy Res; 2014 Aug; 108(6):1087-94. PubMed ID: 24893830
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral metabolism changes in epileptic children receiving valproic acid.
Oner N; Kaya M; Karasalihoğlu S; Karaca H; Celtik C; Tütüncüler F
J Paediatr Child Health; 2004 Aug; 40(8):470-3. PubMed ID: 15265190
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy.
Tsukahara H; Kimura K; Todoroki Y; Ohshima Y; Hiraoka M; Shigematsu Y; Tsukahara Y; Miura M; Mayumi M
Pediatr Int; 2002 Jun; 44(3):247-53. PubMed ID: 11982890
[TBL] [Abstract][Full Text] [Related]
7. [Effect of topiramate and carbamazepine on bone metabolism in children with epilepsy].
Zhang J; Wang KX; Wei Y; Xu MH; Su JM; Bao YG; Zhao SY
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Feb; 12(2):96-8. PubMed ID: 20199720
[TBL] [Abstract][Full Text] [Related]
8. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years.
Kafali G; Erselcan T; Tanzer F
Clin Pediatr (Phila); 1999 Feb; 38(2):93-8. PubMed ID: 10047942
[TBL] [Abstract][Full Text] [Related]
9. Effect of Long-term Carbamazepine Therapy on Bone Health.
Suljic EM; Mehicevic A; Mahmutbegovic N
Med Arch; 2018 Oct; 72(4):262-266. PubMed ID: 30514991
[TBL] [Abstract][Full Text] [Related]
10. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
Serin HM; Koç ZP; Temelli B; Esen İ
Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
[TBL] [Abstract][Full Text] [Related]
11. Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience.
Lin CM; Fan HC; Chao TY; Chu DM; Lai CC; Wang CC; Chen SJ
BMC Pediatr; 2016 May; 16():61. PubMed ID: 27142370
[TBL] [Abstract][Full Text] [Related]
12. The effect of valproate on bone mineral density in adult epileptic patients.
Boluk A; Guzelipek M; Savli H; Temel I; Ozişik HI; Kaygusuz A
Pharmacol Res; 2004 Jul; 50(1):93-7. PubMed ID: 15082034
[TBL] [Abstract][Full Text] [Related]
13. Color vision in epileptic adolescents treated with valproate and carbamazepine.
Verrotti A; Lobefalo L; Priolo T; Rapinese M; Trotta D; Morgese G; Gallenga PE; Chiarelli F
Seizure; 2004 Sep; 13(6):411-7. PubMed ID: 15276145
[TBL] [Abstract][Full Text] [Related]
14. Relationship between Bone Density and Biochemical Markers of Bone among Two Groups Taking Carbamazepine and Sodium Valproate for Epilepsy in Comparison with Healthy Individuals in Yazd.
Rahimdel A; Dehghan A; Moghadam MA; Ardekani AM
Electron Physician; 2016 Nov; 8(11):3257-3265. PubMed ID: 28070260
[TBL] [Abstract][Full Text] [Related]
15. The effects of antiepileptic drugs on the relationships between leptin levels and bone turnover in prepubertal children with epilepsy.
Aksoy A; Sönmez FM; Deger O; Hosver I; Karagüzel G
J Pediatr Endocrinol Metab; 2011; 24(9-10):703-8. PubMed ID: 22145460
[TBL] [Abstract][Full Text] [Related]
16. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.
Voudris KA; Attilakos A; Katsarou E; Drakatos A; Dimou S; Mastroyianni S; Skardoutsou A; Prassouli A; Garoufi A
Epilepsy Res; 2006 Aug; 70(2-3):211-7. PubMed ID: 16781120
[TBL] [Abstract][Full Text] [Related]
17. A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy.
Verrotti A; Agostinelli S; Coppola G; Parisi P; Chiarelli F
Eur J Neurol; 2010 Feb; 17(2):232-7. PubMed ID: 19682062
[TBL] [Abstract][Full Text] [Related]
18. Quantitative bone ultrasound measurements in young females 14-23 years of age.
Klentrou P; Ludwa IA
J Womens Health (Larchmt); 2011 May; 20(5):677-83. PubMed ID: 21351871
[TBL] [Abstract][Full Text] [Related]
19. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.
Pack AM; Morrell MJ; Randall A; McMahon DJ; Shane E
Neurology; 2008 Apr; 70(18):1586-93. PubMed ID: 18443309
[TBL] [Abstract][Full Text] [Related]
20. The anti-epileptic drugs valproate, carbamazepine and levetiracetam cause bone loss and modulate Wnt inhibitors in normal and ovariectomised rats.
Parveen B; Tiwari AK; Jain M; Pal S; Chattopadhyay N; Tripathi M; Vohora D
Bone; 2018 Aug; 113():57-67. PubMed ID: 29758362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
